Polonsky W - Search Results

1

Semaglutide improves health-related quality of life versus placebo when added to standard of care in patients with type 2 diabetes at high cardiovascular risk (SUSTAIN 6).

Jódar E, Michelsen M, Polonsky W, Réa R, Sandberg A, Vilsbøll T, Warren M, Harring S, Ziegler U, Bain S. Jódar E, et al. Among authors: polonsky w. Diabetes Obes Metab. 2020 Aug;22(8):1339-1347. doi: 10.1111/dom.14039. Epub 2020 Apr 27. Diabetes Obes Metab. 2020. PMID: 32227613 Free PMC article. Clinical Trial.

2

Psychological insulin resistance in patients with type 2 diabetes: the scope of the problem.

Polonsky WH, Fisher L, Guzman S, Villa-Caballero L, Edelman SV. Polonsky WH, et al. Diabetes Care. 2005 Oct;28(10):2543-5. doi: 10.2337/diacare.28.10.2543. Diabetes Care. 2005. PMID: 16186296 No abstract available.

3

Patient perspectives on once-weekly medications for diabetes.

Polonsky WH, Fisher L, Hessler D, Bruhn D, Best JH. Polonsky WH, et al. Diabetes Obes Metab. 2011 Feb;13(2):144-9. doi: 10.1111/j.1463-1326.2010.01327.x. Diabetes Obes Metab. 2011. PMID: 21199266

4

A structured self-monitoring of blood glucose approach in type 2 diabetes encourages more frequent, intensive, and effective physician interventions: results from the STeP study.

Polonsky WH, Fisher L, Schikman CH, Hinnen DA, Parkin CG, Jelsovsky Z, Axel-Schweitzer M, Petersen B, Wagner RS. Polonsky WH, et al. Diabetes Technol Ther. 2011 Aug;13(8):797-802. doi: 10.1089/dia.2011.0073. Epub 2011 May 13. Diabetes Technol Ther. 2011. PMID: 21568751 Clinical Trial.

5

The impact of structured blood glucose testing on attitudes toward self-management among poorly controlled, insulin-naïve patients with type 2 diabetes.

Fisher L, Polonsky WH, Parkin CG, Jelsovsky Z, Petersen B, Wagner RS. Fisher L, et al. Diabetes Res Clin Pract. 2012 May;96(2):149-55. doi: 10.1016/j.diabres.2011.12.016. Epub 2012 Jan 20. Diabetes Res Clin Pract. 2012. PMID: 22265215 Clinical Trial.

6

More satisfied, but why? A pooled patient-level analysis of treatment satisfaction following the initiation of insulin glargine vs. comparators in insulin-naïve patients with type 2 diabetes mellitus.

Polonsky W, Traylor L, Wei W, Shi R, Ameer B, Vlajnic A, Nicolucci A. Polonsky W, et al. Diabetes Obes Metab. 2014 Mar;16(3):255-61. doi: 10.1111/dom.12214. Epub 2013 Oct 16. Diabetes Obes Metab. 2014. PMID: 24028669

7

Greater fear of hypoglycaemia with premixed insulin than with basal-bolus insulin glargine and glulisine: patient-reported outcomes from a 60-week randomised study.

Polonsky WH, Thompson S, Wei W, Riddle MC, Chaudhari S, Jackson J, Bruno AS. Polonsky WH, et al. Diabetes Obes Metab. 2014 Nov;16(11):1121-7. doi: 10.1111/dom.12328. Epub 2014 Jul 12. Diabetes Obes Metab. 2014. PMID: 24919603 Clinical Trial.

8

Development of a New Measure for Assessing Glucose Monitoring Device-Related Treatment Satisfaction and Quality of Life.

Polonsky WH, Fisher L, Hessler D, Edelman SV. Polonsky WH, et al. Diabetes Technol Ther. 2015 Sep;17(9):657-63. doi: 10.1089/dia.2014.0417. Epub 2015 Apr 29. Diabetes Technol Ther. 2015. PMID: 25923812

9

Poor medication adherence in diabetes: What's the problem?

Polonsky WH. Polonsky WH. J Diabetes. 2015 Nov;7(6):777-8. doi: 10.1111/1753-0407.12306. Epub 2015 Jun 9. J Diabetes. 2015. PMID: 25929829 No abstract available.

10

Development of a New Measure for Assessing Insulin Delivery Device Satisfaction in Patients with Type 1 and Type 2 Diabetes.

Polonsky WH, Fisher L, Hessler D, Edelman SV. Polonsky WH, et al. Diabetes Technol Ther. 2015 Nov;17(11):773-9. doi: 10.1089/dia.2015.0140. Epub 2015 Jul 13. Diabetes Technol Ther. 2015. PMID: 26167948

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

195 results

Search Page